INCRETIN FUSION POLYPEPTIDES

摘要

This disclosure provides GIP/GLP- 1 dual agonist polypeptides, fusion proteins, and synthetic and conjugated proteins for the treatment of hypoglycemic conditions, e.g., type-2 diabetes.